We are analyzing https://link.springer.com/article/10.1007/s00223-012-9690-6.

Title:
The Role of Fetuin-A in Physiological and Pathological Mineralization | Calcified Tissue International
Description:
Mineralization in higher vertebrates is restricted to bones and teeth. Pathological calcification is mostly known in vasculature but can basically affect all soft tissues. Simply put, tissue mineralization occurs through the interplay of three key determinants: extracellular matrix suitable for mineralization, extracellular levels of inorganic phosphate and calcium, and the levels of mineralization inhibitors that may be expressed systemically or locally. In this article we describe the role of a prototypic systemic inhibitor protein of mineralization, the hepatic plasma protein α2-Heremans-Schmid glycoprotein/fetuin-A. Fetuin-A mediates the formation of stable colloidal mineral–protein complexes called calciprotein particles (CPPs). Thus, fetuin-A is important in the stabilization and clearance of amorphous mineral precursor phases. Efficient clearance of CPPs and, thus, of excess mineral from circulation prevents local buildup of mineral and calcification of soft tissue. Besides calcium phosphate binding, fetuin-A also acts as a carrier for lipids, which may influence calcification, inflammation, and apoptosis. Fetuin-A-deficient (Ahsg −/−) mice show impaired growth of their long bones and premature growth plate closure. We posit that the absence of fetuin-A in the growth plate causes simultaneous lack of calcification inhibition and excess lipid hormone signaling, leading to premature growth plate mineralization and shortened long bones. This suggests that fetuin-A regulates endochondral ossification through mineralization inhibition and lipid (hormone) binding.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

google, scholar, article, pubmed, cas, jahnendechent, calcification, fetuina, mineralization, bone, tissue, role, calcium, protein, fetuin, biol, chem, phosphate, growth, mineral, inhibition, schäfer, heiss, ketteler, formation, human, res, vascular, matrix, particles, access, int, serum, nature, alpha, nephrol, privacy, cookies, content, calcified, calciprotein, mice, calcif, glycoprotein, type, westenfeld, floege, wang, collagen, soc,

Topics {✒️}

calcification-prone fetuin-a-deficient mice month download article/chapter fetuin/alpha2-hs glycoprotein alpha 2-hs glycoprotein/fetuin alpha 2-hs glycoprotein/fetuin colloidal calciprotein particles tgf-beta signaling alpha 2-hs-glycoprotein full article pdf colloidal particles probed nuclear factor kappa willi jahnen-dechent serum protein fetuin bone apatite formation serum-induced calcification plasma alpha2hs glycoprotein zn-alpha 2-glycoprotein alpha 2hs-glycoprotein privacy choices/manage cookies normal human plasma article brylka mineralizing calvaria cells cross-sectional study accelerated vascular calcification mineral carrier protein rabbit alpha2hs-glycoprotein histidine-rich glycoprotein hepatic protein mineralising human bone related subjects atherosclerotic human aorta calcified matrix metabolism atherosclerotic calcified plaque bone–vascular axis fetuin-a-deficient vascular rankl system intracellular calcium phosphate systemic mineral metabolism calciprotein particles regulates endochondral ossification clinical bone physiology noncollagenous bone constituents endochondral bone development calcium phosphate–fetuin european economic area extracellular matrix suitable trypsin inhibitor belonging lethal systemic inflammation zebrafish fin rays ion-milled sections

Questions {❓}

London GM (2009) Bone–vascular axis in chronic kidney disease: a reality?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The Role of Fetuin-A in Physiological and Pathological Mineralization
         description:Mineralization in higher vertebrates is restricted to bones and teeth. Pathological calcification is mostly known in vasculature but can basically affect all soft tissues. Simply put, tissue mineralization occurs through the interplay of three key determinants: extracellular matrix suitable for mineralization, extracellular levels of inorganic phosphate and calcium, and the levels of mineralization inhibitors that may be expressed systemically or locally. In this article we describe the role of a prototypic systemic inhibitor protein of mineralization, the hepatic plasma protein α2-Heremans-Schmid glycoprotein/fetuin-A. Fetuin-A mediates the formation of stable colloidal mineral–protein complexes called calciprotein particles (CPPs). Thus, fetuin-A is important in the stabilization and clearance of amorphous mineral precursor phases. Efficient clearance of CPPs and, thus, of excess mineral from circulation prevents local buildup of mineral and calcification of soft tissue. Besides calcium phosphate binding, fetuin-A also acts as a carrier for lipids, which may influence calcification, inflammation, and apoptosis. Fetuin-A-deficient (Ahsg −/−) mice show impaired growth of their long bones and premature growth plate closure. We posit that the absence of fetuin-A in the growth plate causes simultaneous lack of calcification inhibition and excess lipid hormone signaling, leading to premature growth plate mineralization and shortened long bones. This suggests that fetuin-A regulates endochondral ossification through mineralization inhibition and lipid (hormone) binding.
         datePublished:2013-01-01T00:00:00Z
         dateModified:2013-01-01T00:00:00Z
         pageStart:355
         pageEnd:364
         sameAs:https://doi.org/10.1007/s00223-012-9690-6
         keywords:
            Fetuin-A
            Ectopic calcification
            Chondrocyte
            Matrix protein
            Osteoblast
            Biochemistry
            general
            Endocrinology
            Orthopedics
            Cell Biology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00223-012-9690-6/MediaObjects/223_2012_9690_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00223-012-9690-6/MediaObjects/223_2012_9690_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00223-012-9690-6/MediaObjects/223_2012_9690_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00223-012-9690-6/MediaObjects/223_2012_9690_Fig4_HTML.gif
         isPartOf:
            name:Calcified Tissue International
            issn:
               1432-0827
               0171-967X
            volumeNumber:93
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Laura Brylka
               affiliation:
                     name:RWTH Aachen University
                     address:
                        name:Helmholtz Institute for Biomedical Engineering, Biointerface Group, RWTH Aachen University, Aachen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Willi Jahnen-Dechent
               affiliation:
                     name:RWTH Aachen University
                     address:
                        name:Helmholtz Institute for Biomedical Engineering, Biointerface Group, RWTH Aachen University, Aachen, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The Role of Fetuin-A in Physiological and Pathological Mineralization
      description:Mineralization in higher vertebrates is restricted to bones and teeth. Pathological calcification is mostly known in vasculature but can basically affect all soft tissues. Simply put, tissue mineralization occurs through the interplay of three key determinants: extracellular matrix suitable for mineralization, extracellular levels of inorganic phosphate and calcium, and the levels of mineralization inhibitors that may be expressed systemically or locally. In this article we describe the role of a prototypic systemic inhibitor protein of mineralization, the hepatic plasma protein α2-Heremans-Schmid glycoprotein/fetuin-A. Fetuin-A mediates the formation of stable colloidal mineral–protein complexes called calciprotein particles (CPPs). Thus, fetuin-A is important in the stabilization and clearance of amorphous mineral precursor phases. Efficient clearance of CPPs and, thus, of excess mineral from circulation prevents local buildup of mineral and calcification of soft tissue. Besides calcium phosphate binding, fetuin-A also acts as a carrier for lipids, which may influence calcification, inflammation, and apoptosis. Fetuin-A-deficient (Ahsg −/−) mice show impaired growth of their long bones and premature growth plate closure. We posit that the absence of fetuin-A in the growth plate causes simultaneous lack of calcification inhibition and excess lipid hormone signaling, leading to premature growth plate mineralization and shortened long bones. This suggests that fetuin-A regulates endochondral ossification through mineralization inhibition and lipid (hormone) binding.
      datePublished:2013-01-01T00:00:00Z
      dateModified:2013-01-01T00:00:00Z
      pageStart:355
      pageEnd:364
      sameAs:https://doi.org/10.1007/s00223-012-9690-6
      keywords:
         Fetuin-A
         Ectopic calcification
         Chondrocyte
         Matrix protein
         Osteoblast
         Biochemistry
         general
         Endocrinology
         Orthopedics
         Cell Biology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00223-012-9690-6/MediaObjects/223_2012_9690_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00223-012-9690-6/MediaObjects/223_2012_9690_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00223-012-9690-6/MediaObjects/223_2012_9690_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00223-012-9690-6/MediaObjects/223_2012_9690_Fig4_HTML.gif
      isPartOf:
         name:Calcified Tissue International
         issn:
            1432-0827
            0171-967X
         volumeNumber:93
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Laura Brylka
            affiliation:
                  name:RWTH Aachen University
                  address:
                     name:Helmholtz Institute for Biomedical Engineering, Biointerface Group, RWTH Aachen University, Aachen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Willi Jahnen-Dechent
            affiliation:
                  name:RWTH Aachen University
                  address:
                     name:Helmholtz Institute for Biomedical Engineering, Biointerface Group, RWTH Aachen University, Aachen, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Calcified Tissue International
      issn:
         1432-0827
         0171-967X
      volumeNumber:93
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:RWTH Aachen University
      address:
         name:Helmholtz Institute for Biomedical Engineering, Biointerface Group, RWTH Aachen University, Aachen, Germany
         type:PostalAddress
      name:RWTH Aachen University
      address:
         name:Helmholtz Institute for Biomedical Engineering, Biointerface Group, RWTH Aachen University, Aachen, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Laura Brylka
      affiliation:
            name:RWTH Aachen University
            address:
               name:Helmholtz Institute for Biomedical Engineering, Biointerface Group, RWTH Aachen University, Aachen, Germany
               type:PostalAddress
            type:Organization
      name:Willi Jahnen-Dechent
      affiliation:
            name:RWTH Aachen University
            address:
               name:Helmholtz Institute for Biomedical Engineering, Biointerface Group, RWTH Aachen University, Aachen, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Helmholtz Institute for Biomedical Engineering, Biointerface Group, RWTH Aachen University, Aachen, Germany
      name:Helmholtz Institute for Biomedical Engineering, Biointerface Group, RWTH Aachen University, Aachen, Germany
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(208)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Particles.js
Prism.js

CDN Services {📦}

Crossref

4.14s.

LINK . SPRINGER . COM {}